243 related articles for article (PubMed ID: 27571910)
21. Paraneoplastic movement disorder in a patient with non-Hodgkin's lymphoma and CRMP-5 autoantibody.
Samii A; Dahlen DD; Spence AM; Maronian NC; Kraus EE; Lennon VA
Mov Disord; 2003 Dec; 18(12):1556-8. PubMed ID: 14673901
[TBL] [Abstract][Full Text] [Related]
22. Paraneoplastic motor neuron disease associated with Purkinje cell autoantibody type 1.
Distad BJ; Weiss MD
J Clin Neuromuscul Dis; 2010 Sep; 12(1):36-41. PubMed ID: 20808163
[TBL] [Abstract][Full Text] [Related]
23. [Paraneoplastic optic neuritis in an unknown small cell lung carcinoma defined by CRMP-5-IgG].
Toribio-García JA; Franco-Benito M; García-Ruiz-de-Morales JM
Arch Soc Esp Oftalmol; 2007 Dec; 82(12):777-80. PubMed ID: 18040924
[TBL] [Abstract][Full Text] [Related]
24. Small cell lung cancer associated with anti-Hu paraneoplastic sensory neuropathy and peripheral nerve microvasculitis: case report and literature review.
Ansari J; Nagabhushan N; Syed R; Bomanji J; Bacon CM; Lee SM
Clin Oncol (R Coll Radiol); 2004 Feb; 16(1):71-6. PubMed ID: 14768759
[TBL] [Abstract][Full Text] [Related]
25. Paraneoplastic chorea: case study with autopsy confirmation.
Tremont-Lukats IW; Fuller GN; Ribalta T; Giglio P; Groves MD
Neuro Oncol; 2002 Jul; 4(3):192-5. PubMed ID: 12084350
[TBL] [Abstract][Full Text] [Related]
26. Neuronal autoantibody titers in the course of small-cell lung carcinoma and platinum-associated neuropathy.
Galanis E; Frytak S; Rowland KM; Sloan JA; Lennon VA
Cancer Immunol Immunother; 1999; 48(2-3):85-90. PubMed ID: 10414461
[TBL] [Abstract][Full Text] [Related]
27. Presence of paraneoplastic antibodies in non-carcinomatous patients with neurological involvements of unknown cause.
Yanagihashi M; Kawabe K; Ikeda K
J Neurol Sci; 2013 Dec; 335(1-2):197-200. PubMed ID: 24094858
[TBL] [Abstract][Full Text] [Related]
28. [Paraneoplasic polyneuropathy with anti-amphiphysin antibodies].
Erro ME; Martínez M; Ayuso T; Iragui MI
An Sist Sanit Navar; 2004; 27(1):103-6. PubMed ID: 15146211
[TBL] [Abstract][Full Text] [Related]
29. Lung Cancer Wherein Durvalumab Induced Both Anti-CRMP-5 Antibody-related Paraneoplastic Neurological Syndromes and Neurological Adverse Events.
Seki T; Baba K; Hayashi T; Furuta R; Hirosawa H; Mitsui T; Maesaka H; Takasawa S; Miwa T; Tanaka K; Nakatsuji Y
Intern Med; 2024 Apr; 63(7):1009-1014. PubMed ID: 37612090
[TBL] [Abstract][Full Text] [Related]
30. Orthostatic hypotension secondary to CRMP-5 paraneoplastic autonomic neuropathy.
Neal AJ; Qian MY; Clinch AS; Le BH
J Clin Neurosci; 2014 May; 21(5):885-6. PubMed ID: 24268757
[TBL] [Abstract][Full Text] [Related]
31. Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome.
Mason WP; Graus F; Lang B; Honnorat J; Delattre JY; Valldeoriola F; Antoine JC; Rosenblum MK; Rosenfeld MR; Newsom-Davis J; Posner JB; Dalmau J
Brain; 1997 Aug; 120 ( Pt 8)():1279-300. PubMed ID: 9278623
[TBL] [Abstract][Full Text] [Related]
32. Rare case: paraneoplastic syndrome affecting peripheral nerves, associated with anti-collapsin-response mediator protein-5 (anti-CRMP5) antibodies, as early manifestation of small cell lung cancer confined to a solitary lymph node without evidence of lung mass on routine CT thorax.
Khan U; Warriach SA
BMJ Case Rep; 2020 Feb; 13(2):. PubMed ID: 32033998
[TBL] [Abstract][Full Text] [Related]
33. Paraneoplastic antibodies coexist and predict cancer, not neurological syndrome.
Pittock SJ; Kryzer TJ; Lennon VA
Ann Neurol; 2004 Nov; 56(5):715-9. PubMed ID: 15468074
[TBL] [Abstract][Full Text] [Related]
34. [Paraneoplastic chorea and behavioral disorders in a patient with anti-CV2/CRMP5 antibodies and two different tumors].
Ritzenthaler T; Verret JM; Honnorat J
Rev Neurol (Paris); 2010 Jan; 166(1):90-5. PubMed ID: 19497605
[TBL] [Abstract][Full Text] [Related]
35. New Purkinje cell antibody (PCA-2): marker of lung cancer-related neurological autoimmunity.
Vernino S; Lennon VA
Ann Neurol; 2000 Mar; 47(3):297-305. PubMed ID: 10716248
[TBL] [Abstract][Full Text] [Related]
36. Motor neuron disease as a treatment responsive paraneoplastic neurological syndrome in patient with small cell lung cancer, anti-Hu antibodies and limbic encephalitis.
Cheli M; Dinoto A; Ridolfi M; Sartori A; Stokelj D; Manganotti P
J Neurol Sci; 2019 May; 400():158-159. PubMed ID: 30953906
[No Abstract] [Full Text] [Related]
37. Autoantibodies in neurological paraneoplastic diseases.
Lövblad KO; Boucraut J; Lehmann HP; Stahel R; Regli F; Steck AJ
Schweiz Arch Neurol Psychiatr (1985); 1994; 145(3):3-7. PubMed ID: 7533934
[TBL] [Abstract][Full Text] [Related]
38. Purkinje cell cytoplasmic antibody type 1 (anti-Yo) autoimmunity in a child with Down syndrome.
Philipps G; Alisanski SB; Pranzatelli M; Clardy SL; Lennon VA; McKeon A
JAMA Neurol; 2014 Mar; 71(3):347-9. PubMed ID: 24424854
[TBL] [Abstract][Full Text] [Related]
39. Paraneoplastic anti-Purkinje and type I anti-neuronal nuclear autoantibodies bind selectively to central, peripheral, and autonomic nervous system cells.
Altermatt HJ; Rodriguez M; Scheithauer BW; Lennon VA
Lab Invest; 1991 Oct; 65(4):412-20. PubMed ID: 1921331
[TBL] [Abstract][Full Text] [Related]
40. Multiple paraneoplastic syndromes in a patient with antibodies to neuronal nucleoproteins (anti-Hu).
Heidenreich F; Schober R; Brinck U; Hartung HP
J Neurol; 1995 Mar; 242(4):210-6. PubMed ID: 7798119
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
